Control of Moderate-to-Severe Plaque Psoriasis with Efalizumab: 24-Week, Open-Label, Phase IIIb/IV Latin American Study Results

INTRODUCTION: Psoriasis is a debilitating, chronic inflammatory systemic disease affecting around 2% of the South American population. Biological therapies offer the possibility of long-term therapy with improved safety and efficacy. METHODS: We conducted a multicentre, open-label, single-arm, Phase...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Stengel, Fernando M, Petri, Valeria, Campbell, Gladys AM, Dorantes, Gladys Leon, López, Magdalina, Galimberti, Ricardo L, Valdez, Raúl P, de Arruda, Lucia F, Guerra, Mario Amaya, Chouela, Edgardo N, Licu, Daiana
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Inc 2009
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2805872/
https://ncbi.nlm.nih.gov/pubmed/20098510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1753-5174.2009.00024.x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge